Literature DB >> 23474836

Treatment results of curative gastric resection from a specialist Australian unit: low volume with satisfactory outcomes.

Iain G Thomson1, David C Gotley, Andrew P Barbour, Ian Martin, Neil Jayasuria, Janine Thomas, Bernard M Smithers.   

Abstract

BACKGROUND: The incidence of gastric cancer is decreasing in Australia, yet it remains a common cause of cancer-related mortality. Surgical resection remains the cornerstone of curative treatment. High-volume specialized units have reported superior perioperative and oncological outcomes. The role of D2 lymphadenectomy has been controversial as a result of concerns over increased morbidity. Our aim is to report the perioperative and oncological outcomes of curative gastric resection from a specialist Australian upper GI unit.
METHODS: Data from a prospectively maintained database were reviewed for all patients undergoing curative resection for gastric adenocarcinoma from a single unit during a 12-year period. Perioperative and long-term outcomes were compiled.
RESULTS: There were 255 curative gastric resections during 12 years. An R0 resection was performed in 96 % with a perioperative mortality rate of 1.6 %. A D2 dissection was performed in 85 % of cases in the past 6 years, with no increase in perioperative morbidity or mortality detected. The 5-year overall survival was 53 %.
CONCLUSION: Our results demonstrate that both short- and long-term outcomes of surgical resection in gastric cancer patients, comparable to international high-volume centers, can be achieved in an Australian upper GI unit. A D2 lymph node dissection can be performed safely without any increase in perioperative risk in a specialist unit that has the necessary training but also the perioperative support structures to manage these complex patients.

Entities:  

Mesh:

Year:  2013        PMID: 23474836     DOI: 10.1007/s10120-013-0240-3

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  38 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Enforcing centralization for gastric cancer in Denmark.

Authors:  L S Jensen; H Nielsen; P B Mortensen; H K Pilegaard; S P Johnsen
Journal:  Eur J Surg Oncol       Date:  2010-07-02       Impact factor: 4.424

3.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

4.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

5.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

Review 6.  D1 versus D2 lymphadenectomy for gastric cancer.

Authors:  Benjamin Schmidt; Sam S Yoon
Journal:  J Surg Oncol       Date:  2012-04-18       Impact factor: 3.454

7.  Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.

Authors:  Takeshi Sano; Mitsuru Sasako; Seiichiro Yamamoto; Atsushi Nashimoto; Akira Kurita; Masahiro Hiratsuka; Toshimasa Tsujinaka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura; Kunio Okajima
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

Review 8.  Pancreas-preserving total gastrectomy for proximal gastric cancer.

Authors:  K Maruyama; M Sasako; T Kinoshita; T Sano; H Katai; K Okajima
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

9.  Population-based study of relationship between hospital surgical volume and 5-year survival of stomach cancer patients in Osaka, Japan.

Authors:  Etsuko Nomura; Hideaki Tsukuma; Wakiko Ajiki; Akira Oshima
Journal:  Cancer Sci       Date:  2003-11       Impact factor: 6.716

10.  Extended lymph node dissection for gastric cancer from a European perspective.

Authors:  Johan L Dikken; Marcel Verheij; Annemieke Cats; Edwin P M Jansen; Henk H Hartgrink; Cornelis J H van de Velde
Journal:  Gastric Cancer       Date:  2011-08-12       Impact factor: 7.370

View more
  5 in total

1.  Cortactin expression confers a more malignant phenotype to gastric cancer SGC-7901 cells.

Authors:  Jun Wei; Zhong-Xin Zhao; Yang Li; Zhu-Qing Zhou; Tian-Geng You
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

2.  Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy.

Authors:  Varun Manoharan; Soon Lee; Shanley Chong; June Yap; Nick Coupe; Robert Wilson; Neil Merrett; Weng Ng; Michael Lin
Journal:  Ann Nucl Med       Date:  2017-03-15       Impact factor: 2.668

3.  Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation.

Authors:  Wen-Wen Lu; Hong Zhang; You-Ming Li; Feng Ji
Journal:  World J Gastroenterol       Date:  2017-06-28       Impact factor: 5.742

4.  A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching.

Authors:  Susanna Lam; Elinor Tan; Audrey Menezes; David Martin; James Gallagher; David Storey; Charbel Sandroussi
Journal:  World J Surg Oncol       Date:  2018-07-09       Impact factor: 2.754

5.  Survival outcomes after D1 and D2 lymphadenectomy with R0 resection in stage II-III gastric cancer: Longitudinal follow-up in a single center.

Authors:  Adam Uslu; Baha Zengel; Enver İlhan; Ahmet Aykas; Cenk Şimşek; Orhan Üreyen; Ali Duran; Gökalp Okut
Journal:  Turk J Surg       Date:  2018-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.